Letter to the Editor, "BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction"

被引:1
|
作者
Hogg, S. J. [1 ,2 ]
Johnstone, R. W. [1 ,2 ]
Shortt, J. [1 ,2 ,3 ,4 ]
机构
[1] Peter MacCallum Canc Ctr, Canc Therapeut Program, Melbourne, Vic 8006, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[3] Monash Hlth, Monash Haematol, Clayton, Vic, Australia
[4] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Clin Sci, Monash Hlth, Clayton, Vic, Australia
关键词
N-METHYLPYRROLIDONE; REGENERATION; MEMBRANE;
D O I
10.1177/0022034514557673
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
引用
收藏
页码:229 / 229
页数:1
相关论文
共 50 条
  • [21] BET protein inhibition by JQ1 blocks EWS-FLI1 activity in Ewing sarcoma
    Bledsoe, Krista L.
    Stonestrom, Aaron
    Kadauke, Stephan
    Quick, Laura
    Young, Robert
    Blobel, Gerd A.
    Chou, Margaret M.
    CANCER RESEARCH, 2015, 75
  • [22] Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity
    Sun, Liping
    Liu, Jing
    Yuan, Yanggang
    Zhang, Xinzhou
    Dong, Zheng
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2018, 315 (03) : F469 - F478
  • [23] The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
    Benito, E.
    Ramachandran, B.
    Schroeder, H.
    Schmidt, G.
    Urbanke, H.
    Burkhardt, S.
    Capece, V.
    Dean, C.
    Fischer, A.
    TRANSLATIONAL PSYCHIATRY, 2017, 7 : e1239 - e1239
  • [24] BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
    Belkina, Anna C.
    Nikolajczyk, Barbara S.
    Denis, Gerald V.
    JOURNAL OF IMMUNOLOGY, 2013, 190 (07): : 3670 - 3678
  • [25] Acquired drug-resistance to BET-inhibitor JQ1 in HCT 116 cells
    Noguchi, Kohji
    Katayama, Kazuhiro
    Sugimoto, Yoshikazu
    CANCER SCIENCE, 2018, 109 : 59 - 59
  • [26] Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
    Yamamoto, Keisuke
    Tateishi, Keisuke
    Kudo, Yotaro
    Hoshikawa, Mayumi
    Tanaka, Mariko
    Nakatsuka, Takuma
    Fujiwara, Hiroaki
    Miyabayashi, Koji
    Takahashi, Ryota
    Tanaka, Yasuo
    Ijichi, Hideaki
    Nakai, Yousuke
    Isayama, Hiroyuki
    Morishita, Yasuyuki
    Aoki, Taku
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    Fukayama, Masashi
    Koike, Kazuhiko
    ONCOTARGET, 2016, 7 (38) : 61469 - 61484
  • [27] Chemical Catalysis Guides Structural Identification for the Major In Vivo Metabolite of the BET Inhibitor JQ1
    Holmes, Secondra
    Jain, Prashi
    Rodriguez, Kenneth Guzman
    Williams, Jade
    Yu, Zhifeng
    Cerda-Smith, Christian
    Samuel, Errol L. G.
    Campbell, James
    Hakenjos, John Michael
    Monsivais, Diana
    Li, Feng
    Chamakuri, Srinivas
    Matzuk, Martin M.
    Santini, Conrad
    Mackenzie, Kevin R.
    Young, Damian W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (01): : 107 - 115
  • [28] Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation
    Fourniols, Thibaut
    Maggio, Valentina
    Rafael, Diana
    Colaco, Ariana
    Garcia Vidal, Elia
    Lopes, Alessandra
    Schwartz, Simo
    Martinez-Barriocanal, Agueda
    Preat, Veronique
    Arango, Diego
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2022, 171 : 39 - 49
  • [29] The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer
    Miller, Aubrey L.
    Garcia, Patrick L.
    Fehling, Samuel C.
    Gamblin, Tracy L.
    Vance, Rebecca B.
    Council, Leona N.
    Chen, Dongquan
    Yang, Eddy S.
    van Waardenburg, Robert C. A. M.
    Yoon, Karina J.
    CANCERS, 2021, 13 (14)
  • [30] Small-molecule BET inhibitor JQ1 subdues inflammation in vitro and protects mice from LPS-induced shock
    Belkina, Anna
    Denis, Gerald
    JOURNAL OF IMMUNOLOGY, 2012, 188